CDC Distributing Monkeypox Vaccines Nationwide While Raising Monkeypox Travel Alert to Level 2
On June 6, 2022, the U.S. Centers for Disease Control and Prevention (CDC) raised its monkeypox travel alert to Level 2, warning Americans to “Practice Enhanced Precautions.”1 The agency stated that monkeypox cases have been rising in at least 29 countries, with 1,019 infections reported to date. Currently, the United States has confirmed 31 cases […]
More Monkeypox Cases Identified as Roche is Ready With PCR Tests
There had been 584 confirmed cases of monkeypox virus in 26 countries as of May 31, 2022.1 The largest outbreak is in the United Kingdom where 190 people are infected with the virus, followed by Spain with 132 people infected, and Portugal with 100 people infected. Before this year, monkeypox in humans was thought to […]
Smallpox Vaccine Manufacturers See Big Stock Price Increases After Monkeypox Outbreaks Reported
On May 26, 2022, U.S. Centers for Disease Control (CDC) officials held a press briefing and announced there had been nine cases of monkeypox identified in seven U.S. states and that two licensed smallpox vaccines were in the national stockpile and ready to be distributed.1 The CDC’s director said, “The U.S. has the resources we […]
Monkeypox Cases in U.S. Coincide With Vaccine Purchases by BARDA
The World Health Organization (WHO) announced on May 21, 2022 that more than 100 confirmed or suspected cases of monkeypox had been identified in 12 countries, including between one and five confirmed cases in the U.S.1 Most of the cases have occurred in Europe with higher numbers in Portugal, Spain and the U.K. WHO officials […]
Canada Blocks Unvaccinated People from Boarding Airplanes and Trains
In August 2021, Canadian Prime Minister Justin Trudeau said he would implement a federal COVID-19 vaccine mandate for domestic and international air travelers, inter-provincial rail and cruise ship passengers.1 According to The Globe and Mail, Canada has one of the highest COVID vaccination rates in the world. At least 73 percent of people eligible for […]
Pfizer and Moderna COVID-19 Shots Can Trigger Alopecia Areata in Patients with Autoimmune Conditions
Following the granting by the U.S. Food and Drug Administration (FDA) of Emergency Use Authorization (EUA) status for Pfizer/BioNTech’s BNT162b2 and Moderna/NIAID’s mRNA-1273 messenger RNA (mRNA) COVID-19 biologics in December 2020, there have been increasing reports of alopecia areata following vaccination with these products.1 Alopecia areata is an autoimmune disorder characterized by hair loss due […]
